Double-Blind Placebo-Controlled Trial of Quetiapine in Anorexia Nervosa.

About this resource

Objective: Our objective is to determine whether quetiapine was superior to placebo in increasing weight or reducing core symptoms of anorexia nervosa as assessed by the Yale–Brown–Cornell Eating Disorder Scale and the Eating Disorder Inventory-2. Method: Participants were randomised to 8 weeks of quetiapine or placebo. Results: There are 21 participants who signed informed consent, 15 were randomised, 14 returned for at least one visit after receiving drug and 10 completed the study. There were no differences between drug and placebo in questionnaire scores, weight or measures of anxiety or depression. Discussion: There was no difference between quetiapine and placebo on weight gain or core symptoms. Small effect sizes suggest that a higher number of participants would not increase significant differences between groups. Copyright © 2012 John Wiley & Sons, Ltd and Eating Disorders Association.

AuthorPowers, Ps; Klabunde, M. & Kaye, W.
JournalEuropean Eating Disorders Review
Volume20(1):331-4
Year2012

See also

ED management of patients with eating disorders

BACKGROUND: Eating disorders are one of the "great masqueraders" of the twenty-first century.

Read more

DSM-IV-defined anorexia nervosa versus subthreshold anorexia nervosa (EDNOS-AN)

OBJECTIVES: Eating disorder not otherwise specified (EDNOS) is the most prevalent eating disorder, yet its heterogeneity begs less reliance on this broad diagnostic category.

Read more

The effects of intranasal oxytocin on smoothie intake, cortisol and attentional bias in anorexia nervosa.

BACKGROUND: Anorexia nervosa (AN) is characterised by severe malnutrition as well as intense fear and anxiety around food and eating with associated anomalies in information processing.

Read more

the findings of this study suggest that organic or psychiatric comorbidities and some data of social normality might be more relevant to QoL in ED than age

Read more

Help us improve!

Give us feedback!

We will continue throughout 2019 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback